EGFR and lung carcinoma: Moreover, Hiroaki and his colleagues suggested that IL-18-induced APC-like NK cells derived from patients with lung cancer treated with an anti-EGFR monoclonal antibody exert antitumor effects on the lung cancer cell line PC-9 through antibody-dependent cell-mediated cytotoxicity (ADCC) 106.